The present invention relates to compounds of formula (I)which are capable of inhibiting the 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD1), to processes for preparing these compounds, to pharmaceutical compositions comprising an effective amount of these compounds and to the use of the compounds in medicine in particular for the treatment of pathological conditions or diseases that can improve by inhibition of 11-beta-HSD1.